Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk

Phase 4 Completed 59 enrolled Lisa Haddad Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab

Non-randomizedParallel-groupOpen-labelBasic science

Summary

This is a prospective cohort study focusing on HIV negative women. The investigators want to learn how the contraceptive methods of depot medroxyprogesterone acetate (DMPA), etonogestrel implant (Eng-Implant), levonorgestrel intrauterine device (Lng-IUD) and the ParaGard® T 380A Intrauterine Copper Contraceptive impact the vaginal immune environment.

Timeline

Start: 2015-02
Primary completion: 2019-10-23
Completion: 2019-10-23

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	medroxyprogesterone acetate	Other / unclassified	150 mg	Intramuscular

Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk

Summary

Timeline

Drugs

Indications